HealthStream (NASDAQ:HSTM) Releases Quarterly Earnings Results, Beats Estimates By $0.04 EPS

HealthStream (NASDAQ:HSTM) posted its quarterly earnings data on Monday. The technology company reported $0.20 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.04, Zacks reports. The company had revenue of $81.20 million during the quarter, compared to analysts’ expectations of $79.68 million. HealthStream had a return on equity of 6.47% and a net margin of 6.39%.

HealthStream Stock Performance

NASDAQ HSTM traded down $1.38 during trading hours on Wednesday, hitting $22.98. 27,016 shares of the company traded hands, compared to its average volume of 305,616. The business’s 50-day moving average is $21.12 and its 200-day moving average is $22.62. HealthStream has a twelve month low of $19.50 and a twelve month high of $29.63. The stock has a market capitalization of $676.19 million, a price-to-earnings ratio of 34.30, a P/E/G ratio of 2.44 and a beta of 0.41.

HealthStream Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 29th. Investors of record on Monday, May 18th will be given a dividend of $0.035 per share. The ex-dividend date of this dividend is Monday, May 18th. This represents a $0.14 annualized dividend and a yield of 0.6%. HealthStream’s dividend payout ratio is 22.95%.

Institutional Trading of HealthStream

Institutional investors and hedge funds have recently bought and sold shares of the business. Aquatic Capital Management LLC bought a new stake in HealthStream in the third quarter valued at approximately $40,000. Tower Research Capital LLC TRC raised its stake in HealthStream by 241.4% in the second quarter. Tower Research Capital LLC TRC now owns 2,407 shares of the technology company’s stock valued at $67,000 after buying an additional 1,702 shares during the period. State of Wyoming bought a new stake in HealthStream in the second quarter valued at approximately $106,000. Virtus Advisers LLC bought a new stake in HealthStream in the third quarter valued at approximately $142,000. Finally, BNP Paribas Financial Markets raised its stake in HealthStream by 101.7% in the third quarter. BNP Paribas Financial Markets now owns 5,241 shares of the technology company’s stock valued at $148,000 after buying an additional 2,642 shares during the period. Institutional investors own 69.58% of the company’s stock.

HealthStream declared that its Board of Directors has approved a stock repurchase plan on Friday, March 13th that authorizes the company to buyback $10.00 million in shares. This buyback authorization authorizes the technology company to purchase up to 1.7% of its shares through open market purchases. Shares buyback plans are usually a sign that the company’s board believes its stock is undervalued.

Analysts Set New Price Targets

Several research analysts have recently weighed in on HSTM shares. Weiss Ratings cut HealthStream from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, March 18th. Citigroup reissued a “market perform” rating on shares of HealthStream in a research report on Tuesday, January 6th. Finally, Canaccord Genuity Group set a $24.00 price target on HealthStream in a research report on Wednesday. Two analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Reduce” and a consensus price target of $24.00.

About HealthStream

HealthStream, Inc is a Nashville, Tennessee–based provider of workforce development and learning management solutions for healthcare organizations. Since its founding in 1990, the company has focused on helping hospitals, clinics and other care providers streamline staff training, ensure regulatory compliance and monitor employee performance. HealthStream’s platform integrates online courses, skill competency assessments and credential management tools to support workforce readiness across the healthcare continuum.

The company’s core offerings include a learning management system (LMS) designed specifically for clinical and nonclinical personnel, a competency management suite that tracks skill acquisition and validation, and a content library featuring evidence-based clinical and compliance training modules.